氨基胍对大鼠体外全骨髓诱导破骨细胞分化的影响
本文选题:氨基胍 切入点:破骨细胞 出处:《山西医科大学》2017年硕士论文
【摘要】:目的:研究不同浓度氨基胍对大鼠体外全骨髓诱导破骨细胞分化的影响,为骨质疏松性疾病药物治疗提供实验依据。方法:选用全骨髓诱导法培养破骨细胞(Osteoclast,OC),在培养当天各组分别加入浓度为0mM、0.1mM、1mM、2.5mM的氨基胍(Aminoguanidine,AG),于第10天行抗酒石酸酸性磷酸酶(Tartrate-resistant acid phosphatase,TRAP)染色,观察TRAP阳性细胞数的差异;于培养第10天进行扫描电镜检测骨陷窝发生的情况;于培养第10天收集细胞行RT-PCR检测,测定OC特异性标志物核因子-κB受体活化因子(Receptor activator of nuclear,RANK)和组织蛋白酶K(CathepsinK,CK)mRNA的表达量;于培养第10天收集细胞行Western Blot检测OC活化信号通道蛋白P38和P65的表达量,及其测晚期糖基化终末产物(Advanced glycation end products,AGEs)和晚期糖基化终末产物受体(Receptor for advanced glycation end products,AGER)的表达量。结果:TRAP染色观察示:不同浓度AG干预后,能够起到促进OC生成的作用,随AG浓度增加,出现红染细胞数逐渐增多,各组间差异有统计学意义,P0.05;骨吸收实验示:不同浓度AG干预后,能够促进骨陷窝生成;RT-PCR检测结果示:不同浓度AG干预后,能够促进OC形成,随AG浓度的增加,OC特异标志物RANK和CathepsinK的mRNA表达量逐渐增加,各组间差异有统计学意义;Western Blot检测结果示:不同浓度AG干预后,能够促进OC形成,随AG浓度的增加,P38和P65的表达量逐渐增加,同时检测AGEs及其受体AGER的表达量逐渐降低,差异有统计学意义。结论:1.AG可以降低体外全骨髓诱导OC中AGEs和AGER的含量,在本实验中起到了抑制AGEs及其受体AGER的作用,呈剂量依赖性。2.AG能够增加体外全骨髓诱导OC的形成,在本实验浓度范围内促进了OC分化,呈剂量依赖性。
[Abstract]:Objective: to study the effects of different concentrations of aminoguanidine on osteoclast differentiation induced by whole bone marrow of rats in vitro. Methods: osteoclasts of osteoclasts were cultured by whole bone marrow induction method. Aminoguanidine Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Aminoguanidine (Aminoguanidine) Amin@@. The number of TRAP positive cells was observed, the incidence of bone lacuna was detected by scanning electron microscope on the 10th day of culture, and the RT-PCR was detected by RT-PCR on the 10th day of culture. The expression of nuclear factor 魏 B receptor activator activator of nuclear receptor activator activator of nuclear receptor (RANKK) and cathepsin Knk mRNA were measured, and the expression of OC-activated signal channel proteins P38 and p65 were detected by Western Blot on the 10th day of culture, and the expression of OC-activated signal channel protein p38 and p65 were detected by Western Blot. The expression of advanced glycation end products (ages) and late glycosylation end product receptor (Receptor for advanced glycation end products agers) were measured. The number of red stained cells increased gradually, and the difference was statistically significant (P 0.05). The results of bone absorption test showed that AG at different concentrations could promote the formation of bone lacunae by RT-PCR. With the increase of AG concentration, the mRNA expression of RANK and CathepsinK, the specific markers of OC, increased gradually. The results of Western Blot analysis showed that the different concentrations of AG could promote the formation of OC. With the increase of AG concentration, the expression of P38 and p65 increased, and the expression of AGEs and its receptor AGER decreased gradually. Conclusion: 1. AG can reduce the content of AGEs and AGER in bone marrow induced OC in vitro. In this experiment, AGEs and its receptor AGER were inhibited in a dose-dependent manner. 2. AG could increase the formation of OC induced by whole bone marrow in vitro, and promote the differentiation of OC in a dose-dependent manner.
【学位授予单位】:山西医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R580
【参考文献】
相关期刊论文 前10条
1 曾艳平;杨超;杨红军;樊勇;吴子祥;刘斌;苏菲;白博;张文强;桑宏勋;;阿司匹林体外抑制破骨细胞生成的分子机制研究[J];中国骨质疏松杂志;2015年03期
2 赵帅;何爱咏;陶澄;;不同剂量骨保护素对破骨细胞内一氧化氮生成及内皮型一氧化氮合酶的影响[J];中国组织工程研究;2014年42期
3 张志伟;刘昌戎;廖金辉;沈为栋;;骨质疏松症与一氧化氮、内皮素、降钙素基因相关肽的关系研究进展[J];中华实验外科杂志;2014年09期
4 韦蓉梅;董丽平;吴红慧;徐燕群;张健清;;强直性脊柱炎患者骨代谢生化指标和RANKL-RANK-OPG系统表达之间的相关性[J];现代生物医学进展;2013年13期
5 张凌云;曲秀娟;刘云鹏;侯科佐;;PI3K/Akt信号通路在RANKL诱导的MCF-7乳腺癌细胞迁移中的作用[J];现代肿瘤医学;2012年02期
6 仲蕾蕾;杨冰;黄晓斌;孙元明;;OPG/RANKL/RANK系统在成骨细胞和破骨细胞相互调节中的作用[J];中国骨质疏松杂志;2011年11期
7 陈建勇;王聪;王娟;曹礼荣;;MAPK信号通路研究进展[J];中国医药科学;2011年08期
8 刘中浩;高红伟;邢德国;赵锡武;王若义;宫明智;;糖尿病性骨质疏松模型雌激素、一氧化氮及转化生长因子β1的变化[J];中国组织工程研究与临床康复;2011年11期
9 葛冬霞;李良;吴江;陈槐卿;;1,25(OH)_2维生素D_3诱导大鼠骨髓单核细胞形成破骨细胞[J];四川大学学报(医学版);2007年02期
10 杨海平,王东,蔚晋斌,张登峰,武展雄;同种异体骨复合氨基胍对兔桡骨缺损愈合的影响[J];中国矫形外科杂志;2005年04期
,本文编号:1684337
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1684337.html